Made Harumi Padmaswari Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
unknown
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Made Harumi Padmaswari's research focuses on the preclinical development of genome editing strategies for Duchenne muscular dystrophy. Her work investigates the delivery challenges associated with CRISPR-Cas9 technology for this genetic disorder, exploring methods to optimize its efficacy in treating muscle disease. Padmaswari has published research on improving recombinant Cas9 expression for enhanced protein purification and genome editing applications. She also studies the precision and efficacy of RNA-guided DNA integration in muscle tissue and the complex genomic and transcriptomic changes that can occur with AAV-CRISPR therapy. Her publications include work on exon skipping as a therapeutic approach for Duchenne muscular dystrophy. Padmaswari collaborates with researchers at the University of Arkansas at Fayetteville, including Christopher E. Nelson and Shilpi Agrawal, with whom she has co-authored multiple publications.
Metrics
- h-index: 2
- Publications: 6
- Citations: 26
Selected Publications
-
Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy (2025)
-
Preclinical development of genome editing to treat Duchenne muscular dystrophy by exon skipping (2025)
-
Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci (2024)
-
Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing (2024)
-
Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci (2024)
-
Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy (2023)
Collaboration Network
Top Collaborators
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Preclinical development of genome editing to treat Duchenne muscular dystrophy by exon skipping
Showing 5 of 6 shared publications
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Preclinical development of genome editing to treat Duchenne muscular dystrophy by exon skipping
Showing 5 of 6 shared publications
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
Similar Researchers
Based on overlapping research topics